RXRX insider receives 4,607 shares in stock awards
By AlphaYouPublished Form 4
Dar Zavain
Reporting filer
Dar Zavain reported 4,607 shares of Class A Common Stock in RECURSION PHARMACEUTICALS, INC. as grants or awards dated 2026-10-01. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dar Zavain | 2026-10-01 | A | Grant or award | 4607 | 0 | 245,371 | 1 day | Filed terms
|
Class A Common Stock
- Owner
- Dar Zavain
- Date
- 2026-10-01
- Code
- A
- Action
- Grant or award
- Quantity
- 4607
- Price
- 0
- Following holdings
- 245,371
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Class A Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 4607
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 245371
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Dar Zavain: Director.
- F1: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
Original sources
Prepared automatically from public filing data. Report a correction.